Trial Profile
Sofosbuvir and Daclatasvir Therapy for Recurrent Hepatitis C after Liver Transplantation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Aug 2015 New trial record
- 14 Jul 2015 Results published in the BMJ Case Reports.